Results of Annual General Meeting 28 November 2018
2018_11_28_BTC_1543417620
Chairman’s Address to Shareholders 2018
2018_11_28_BTC_1543415220
BioImpact licenses episil for Australia and New Zealand
2018_11_25_BTC_1543135080
Net Tangible Asset Backing – 31 October 2018
2018_11_05_BTC_1541404838
Notice of Annual General Meeting/Proxy Form
2018_10_26_BTC_1540540837
Net Tangible Asset Backing – 30 September 2018
2018_10_03_BTC_1538553636
Net Tangible Asset Backing – 31 August 2018
2018_09_06_BTC_1536220835
Annual Report to Shareholders 30 June 2018
2018_08_21_BTC_1534838434
Appendix 4G 30 June 2018
2018_08_21_BTC_1534838433
Appendix 4E and Financial Report 30 June 2018
2018_08_21_BTC_1534838432